Metabolomic Quality Assessment of EDTA Plasma and Serum Samples.

Handling and processing of blood can significantly alter the molecular composition and consistency of biobank samples and can have a major impact on the identification of biomarkers. It is thus crucial to identify tools to determine the quality of samples to be used in biomarker discovery studies. In this study, a non-targeted gas chromatography/time-of-flight mass spectrometry (GC-TOFMS) metabolomic strategy was used with the aim of identifying quality markers for serum and plasma biobank collections lacking proper documentation of preanalytical handling. The effect of postcentrifugation delay was examined in serum stored in tubes with gel separation plugs and ethylenediaminetetraacetic acid (EDTA) plasma in tubes with or without gel separation plugs. The change in metabolic pattern was negligible in all sample types processed within 3 hours after centrifugation regardless of whether the samples were kept at 4°C or 22°C. After 8 and 24 hours postcentrifugation delay before aliquoting, there was a pronounced increase in the number of affected metabolites, as well as in the magnitude of the observed changes. No protective effect on the metabolites was observed in gel-separated EDTA plasma samples. In a separate series of experiments, lactate and glucose levels were determined in plasma to estimate the effect of precentrifugation delay. This separate experiment indicates that the lactate to glucose ratio may serve as a marker to identify samples with delayed time to centrifugation. Although our data from the untargeted GC-TOFMS analysis did not identify any specific markers, we conclude that plasma and serum metabolic profiles remain quite stable when plasma and serum are centrifuged and separated from the blood cells within 3 hours.

[1]  Thomas Burke,et al.  Human Biospecimen Research: Experimental Protocol and Quality Control Tools , 2009, Cancer Epidemiology Biomarkers & Prevention.

[2]  Fotini Betsou,et al.  Influence of common preanalytical variations on the metabolic profile of serum samples in biobanks , 2011, Journal of biomolecular NMR.

[3]  Patrick F. Sullivan,et al.  LifeGene—a large prospective population-based study of global relevance , 2010, European Journal of Epidemiology.

[4]  Jim Vaught,et al.  Preanalytical variables affecting the integrity of human biospecimens in biobanking. , 2015, Clinical chemistry.

[5]  Paul Geladi,et al.  Principal Component Analysis , 1987, Comprehensive Chemometrics.

[6]  Gabi Kastenmüller,et al.  Pre-Analytical Sample Quality: Metabolite Ratios as an Intrinsic Marker for Prolonged Room Temperature Exposure of Serum Samples , 2015, PloS one.

[7]  J. Trygg,et al.  Extraction and GC/MS analysis of the human blood plasma metabolome. , 2005, Analytical chemistry.

[8]  Paul Elliott,et al.  The UK Biobank sample handling and storage validation studies. , 2008, International journal of epidemiology.

[9]  Nigel W. Hardy,et al.  Summary recommendations for standardization and reporting of metabolic analyses , 2005, Nature Biotechnology.

[10]  Andreas Zell,et al.  Preanalytical aspects and sample quality assessment in metabolomics studies of human blood. , 2013, Clinical chemistry.

[11]  L. Weinehall,et al.  Cardiovascular disease and diabetes in the Northern Sweden Health and Disease Study Cohort- evaluation of risk factors and their interactions , 2003, Scandinavian journal of public health. Supplement.

[12]  S. Wold,et al.  Orthogonal projections to latent structures (O‐PLS) , 2002 .

[13]  Paolo Vineis,et al.  Performance in Omics Analyses of Blood Samples in Long-Term Storage: Opportunities for the Exploitation of Existing Biobanks in Environmental Health Research , 2013, Environmental health perspectives.

[14]  B. Han,et al.  Identification of clinical biomarkers for pre-analytical quality control of blood samples. , 2013, Biopreservation and biobanking.

[15]  D. Postma,et al.  Universal risk factors for multifactorial diseases , 2007, European Journal of Epidemiology.

[16]  Ivano Bertini,et al.  Standard operating procedures for pre-analytical handling of blood and urine for metabolomic studies and biobanks , 2011, Journal of biomolecular NMR.

[17]  Fotini Betsou,et al.  Identification of evidence-based biospecimen quality-control tools: a report of the International Society for Biological and Environmental Repositories (ISBER) Biospecimen Science Working Group. , 2013, The Journal of molecular diagnostics : JMD.

[18]  Johan Lindberg,et al.  Predictive metabolite profiling applying hierarchical multivariate curve resolution to GC-MS data--a potential tool for multi-parametric diagnosis. , 2006, Journal of proteome research.

[19]  Erik Peter,et al.  Quality markers addressing preanalytical variations of blood and plasma processing identified by broad and targeted metabolite profiling. , 2014, Clinical chemistry.

[20]  Kenneth E Blick,et al.  Stability studies of twenty-four analytes in human plasma and serum. , 2002, Clinical chemistry.

[21]  M. Sjöström,et al.  Design of experiments: an efficient strategy to identify factors influencing extraction and derivatization of Arabidopsis thaliana samples in metabolomic studies with gas chromatography/mass spectrometry. , 2004, Analytical biochemistry.